Phreesia Sets Release Date for Fiscal Second Quarter 2025 Results
Phreesia (NYSE: PHR) has announced the release date for its fiscal second quarter 2025 financial results. The company will publish its quarterly results and stakeholder letter after market close on Wednesday, September 4, 2024. A conference call to discuss the results will follow at 5 PM Eastern Time. Investors can participate by dialing (800) 715-9871 (US) or (646) 307-1963 (international) using code 7404611. The call will also be available via webcast on Phreesia's investor website.
Phreesia, founded in 2005, is a leader in patient activation, providing tools for healthcare providers, life sciences companies, and payers. In 2023, the company facilitated approximately 150 million patient visits, representing over 10% of U.S. healthcare visits. Phreesia offers digital solutions for patient intake, outreach, and education to enhance patient experience and improve healthcare outcomes.
Phreesia (NYSE: PHR) ha annunciato la data di rilascio dei risultati finanziari per il secondo trimestre fiscale del 2025. L'azienda pubblicherà i risultati trimestrali e la lettera agli stakeholder dopo la chiusura del mercato, il mercoledì 4 settembre 2024. Seguirà una conferenza telefonica per discutere i risultati alle 5 PM ora orientale. Gli investitori possono partecipare chiamando il (800) 715-9871 (USA) o il (646) 307-1963 (internazionale) utilizzando il codice 7404611. La chiamata sarà anche disponibile via webcast sul sito web degli investitori di Phreesia.
Fondata nel 2005, Phreesia è leader nell'attivazione dei pazienti, fornendo strumenti per i fornitori di assistenza sanitaria, le aziende delle scienze della vita e i pagatori. Nel 2023, l'azienda ha facilitato circa 150 milioni di visite dei pazienti, rappresentando oltre il 10% delle visite sanitarie negli Stati Uniti. Phreesia offre soluzioni digitali per l’accoglienza dei pazienti, il contatto e l’educazione per migliorare l’esperienza del paziente e i risultati sanitari.
Phreesia (NYSE: PHR) ha anunciado la fecha de publicación de sus resultados financieros del segundo trimestre fiscal de 2025. La compañía publicará sus resultados trimestrales y la carta a los interesados después del cierre del mercado el miércoles 4 de septiembre de 2024. Una llamada de conferencia para discutir los resultados seguirá a las 5 PM Hora del Este. Los inversores pueden participar marcando el (800) 715-9871 (EE. UU.) o el (646) 307-1963 (internacional) usando el código 7404611. La llamada también estará disponible a través de webcast en el sitio web de inversores de Phreesia.
Fundada en 2005, Phreesia es un líder en la activación de pacientes, proporcionando herramientas para proveedores de atención médica, empresas de ciencias de la vida y pagadores. En 2023, la compañía facilitó aproximadamente 150 millones de visitas de pacientes, lo que representa más del 10% de las visitas de atención médica en EE. UU. Phreesia ofrece soluciones digitales para la admisión de pacientes, contacto y educación para mejorar la experiencia del paciente y los resultados en salud.
Phreesia (NYSE: PHR)는 2025 회계년도 2분기 재무 결과 발표 날짜를 발표했습니다. 이 회사는 2024년 9월 4일 수요일 장 마감 후 분기별 결과 및 이해관계자 편지를 발표할 것입니다. 결과를 논의하기 위한 컨퍼런스 콜이 동부 표준시 오후 5시에 이어질 예정입니다. 투자자들은 (800) 715-9871 (미국) 또는 (646) 307-1963 (국제)로 전화하여 코드 7404611을 사용하여 참여할 수 있습니다. 이 통화는 또한 Phreesia의 투자자 웹사이트를 통해 웹캐스트로 제공됩니다.
2005년에 설립된 Phreesia는 환자 활성화의 선두주자로, 의료 제공자, 생명과학 회사 및 지불자를 위한 도구를 제공합니다. 2023년에 이 회사는 약 1억 5천만 건의 환자 방문을 지원하여 미국 의료 방문의 10% 이상을 차지했습니다. Phreesia는 환자 접수, 홍보 및 교육을 위한 디지털 솔루션을 제공하여 환자 경험을 향상하고 의료 결과를 개선합니다.
Phreesia (NYSE: PHR) a annoncé la date de publication de ses résultats financiers pour le deuxième trimestre fiscal 2025. L'entreprise publiera ses résultats trimestriels et sa lettre aux parties prenantes après la fermeture du marché, le mercredi 4 septembre 2024. Une conférence téléphonique pour discuter des résultats suivra à 17h, heure de l'Est. Les investisseurs peuvent participer en composant le (800) 715-9871 (États-Unis) ou le (646) 307-1963 (international) en utilisant le code 7404611. L'appel sera également disponible via webdiffusion sur le site des investisseurs de Phreesia.
Fondée en 2005, Phreesia est un leader dans l'activation des patients, fournissant des outils pour les prestataires de soins de santé, les entreprises des sciences de la vie et les payeurs. En 2023, l'entreprise a facilité environ 150 millions de visites de patients, représentant plus de 10% des visites de soins de santé aux États-Unis. Phreesia offre des solutions numériques pour l'admission des patients, les sensibilisations et l'éducation afin d'améliorer l'expérience des patients et les résultats en matière de santé.
Phreesia (NYSE: PHR) hat das Veröffentlichungsdatum für die finanziellen Ergebnisse des zweiten Geschäftsjahresquartals 2025 bekannt gegeben. Das Unternehmen wird seine Quartalsergebnisse und den Stakeholder-Brief nach Börsenschluss am Mittwoch, den 4. September 2024 veröffentlichen. Eine Telefonkonferenz zur Diskussion der Ergebnisse wird um 17 Uhr Eastern Time folgen. Investoren können teilnehmen, indem sie (800) 715-9871 (USA) oder (646) 307-1963 (international) wählen und den Code 7404611 verwenden. Der Anruf wird auch über ein Webcast auf der Investoren-Website von Phreesia verfügbar sein.
Phreesia, 2005 gegründet, ist führend in der Patientenaktivierung und bietet Werkzeuge für Healthcare-Anbieter, Unternehmen im Bereich Lebenswissenschaften und Kostenträger. Im Jahr 2023 erleichterte das Unternehmen etwa 150 Millionen Patientenbesuche, was über 10% der US-amerikanischen Gesundheitsbesuche ausmacht. Phreesia bietet digitale Lösungen für Patientenaufnahme, Outreach und Education, um die Patientenerfahrung zu verbessern und die Gesundheitsergebnisse zu optimieren.
- Phreesia enabled approximately 150 million patient visits in 2023, representing over 10% of U.S. healthcare visits
- The company has established itself as a trusted leader in patient activation since its founding in 2005
- None.
ALL-REMOTE COMPANY/
To participate in the company's live conference call and webcast, please dial (800) 715-9871, or (646) 307-1963 for international participants, using conference code number 7404611, or visit the “Events & Presentations” section of ir.phreesia.com. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.
ABOUT PHREESIA
Phreesia is a trusted leader in patient activation, giving providers, life sciences companies, payers and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled approximately 150 million patient visits in 2023—more than 1 in 10 visits across the U.S.—scale that we believe allows us to make meaningful impact. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives efficiency and improves healthcare outcomes. To learn more, visit phreesia.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240801016965/en/
Investors:
Balaji Gandhi
Phreesia, Inc.
investors@phreesia.com
(929) 506-4950
Media:
Nicole Gist
Phreesia, Inc.
nicole.gist@phreesia.com
(407) 760-6274
Source: Phreesia, Inc.
FAQ
When will Phreesia (PHR) release its fiscal Q2 2025 financial results?
How can investors participate in Phreesia's (PHR) Q2 2025 earnings call?
What percentage of U.S. healthcare visits did Phreesia (PHR) facilitate in 2023?
What services does Phreesia (PHR) offer in the healthcare sector?
